MBRXMoleculin Biotech, Inc.
Earnings
When Moleculin Biotech, Inc. reports, what it reported each quarter, and how the stock took the results.
44 quarters. Sep 30, 2015 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
10-K due Mar 15 – 26
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 8 filings.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 15 – 26
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $0.00
- Revenue, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- Net income
- $15.55M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2021 n/m, Q2 2021 n/m, Q1 2021 n/m, Q3 2020 n/m
Latest results
- Q3 2026Nov 13, 2026, after the close
- Revenue
- $0.00
- —
- Net income
- -$6.49M
- N/M
- EPS
- —
- —
- Revenue
- $0.00
- —
- Net income
- -$7.64M
- N/M
- EPS
- —
- —
- Revenue
- $0.00
- —
- Net income
- -$12.85M
- N/M
- EPS
- —
- —
- Revenue
- $0.00
- —
- Net income
- $15.55M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | — | Nov 13, 2026 | 44 d | 10-Q | $0.00 | — | — | — | |
| Q2 2026 | Jun 30, 2026 | — | Aug 13, 2026 | 44 d | 10-Q | $0.00 | — | — | +5.8% | |
| Q1 2026 | Mar 31, 2026 | — | May 14, 2026 | 44 d | 10-Q | $0.00 | — | — | 4.1% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 18, 2026 | 77 d | 10-K | $0.00 | — | — | 1.0% | |
| Q3 2025 | Sep 30, 2025 | — | Nov 13, 2025 | 44 d | 10-Q | $0.00 | — | — | 4.4% | |
| Q2 2025 | Jun 30, 2025 | — | Aug 12, 2025 | 43 d | 10-Q | $0.00 | — | — | +1.5% | |
| Q1 2025 | Mar 31, 2025 | — | May 13, 2025 | 43 d | 10-Q | $0.00 | — | — | 6.1% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 21, 2025 | 80 d | 10-K | $0.00 | — | — | 3.6% | |
| Q3 2024 | Sep 30, 2024 | — | Nov 8, 2024 | 39 d | 10-Q | $0.00 | — | — | 0.4% | |
| Q2 2024 | Jun 30, 2024 | — | Aug 13, 2024 | 44 d | 10-Q | $0.00 | — | — | +10.1% | |
| Q1 2024 | Mar 31, 2024 | — | May 10, 2024 | 40 d | 10-Q | $0.00 | — | — | 4.5% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 22, 2024 · after-hours | Mar 22, 2024 | 82 d | 10-K | $0.00 | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · pre-market | Nov 13, 2023 | 44 d | 10-Q | $0.00 | — | — | — | |
| Q2 2023 | Jun 30, 2023 | — | Aug 10, 2023 | 41 d | 10-Q | $0.00 | — | — | — | |
| Q1 2023 | Mar 31, 2023 | — | May 10, 2023 | 40 d | 10-Q | $0.00 | — | — | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 22, 2023 | 81 d | 10-K | $0.00 | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · after-hours | Nov 10, 2022 | 41 d | 10-Q | $0.00 | — | — | — | |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | $0.00 | — | — | — | |
| Q1 2022 | Mar 31, 2022 | — | May 11, 2022 | 41 d | 10-Q | $0.00 | — | — | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 24, 2022 | 83 d | 10-K | $0.00 | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 10, 2021 | 41 d | 10-Q | $0.00 | — | -$0.15 | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 11, 2021 | 42 d | 10-Q | $0.00 | — | -$0.15 | — | |
| Q1 2021 | Mar 31, 2021 | May 12, 2021 · pre-market | May 12, 2021 | 42 d | 10-Q | $0.00 | — | -$0.20 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | Mar 24, 2021 · pre-market | Mar 24, 2021 | 83 d | 10-K | $0.00 | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 12, 2020 | 43 d | 10-Q | $0.00 | — | -$0.33 | — | |
| Q2 2020 | Jun 30, 2020 | Aug 12, 2020 · pre-market | Aug 12, 2020 | 43 d | 10-Q | $0.00 | — | -$1.02 | — | |
| Q1 2020 | Mar 31, 2020 | — | May 11, 2020 | 41 d | 10-Q | $0.00 | — | -$0.15 | — | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | Mar 19, 2020 · after-hours | Mar 19, 2020 | 79 d | 10-K | $0.00 | — | — | — | |
| Q3 2019 | Sep 30, 2019 | Nov 12, 2019 · pre-market | Nov 12, 2019 | 43 d | 10-Q | $0.00 | — | -$0.09 | — | |
| Q2 2019 | Jun 30, 2019 | Aug 16, 2019 · after-hours | Aug 16, 2019 | 47 d | 10-Q | $0.00 | — | -$0.03 | — | |
| Q1 2019 | Mar 31, 2019 | — | May 13, 2019 | 43 d | 10-Q | $0.00 | — | -$0.14 | — | |
| FY 2018 | ||||||||||
| Q4 2018derived | Dec 31, 2018 | Feb 21, 2019 · after-hours | Feb 21, 2019 | 52 d | 10-K | $0.00 | — | — | — | |
| Q3 2018 | Sep 30, 2018 | Nov 13, 2018 · pre-market | Nov 13, 2018 | 44 d | 10-Q | $0.00 | — | -$0.08 | — | |
| Q2 2018 | Jun 30, 2018 | — | Aug 10, 2018 | 41 d | 10-Q | $0.00 | — | -$0.20 | — | |
| Q1 2018 | Mar 31, 2018 | — | May 14, 2018 | 44 d | 10-Q | $0.00 | — | -$0.08 | — | |
| FY 2017 | ||||||||||
| Q4 2017derived | Dec 31, 2017 | Mar 28, 2018 · pre-market | Mar 28, 2018 | 87 d | 10-K | $0.00 | — | — | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 13, 2017 | 44 d | 10-Q | $0.00 | — | -$0.14 | — | |
| Q2 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | $0.00 | — | -$0.19 | — | |
| Q1 2017 | Mar 31, 2017 | — | May 12, 2017 | 42 d | 10-Q | $0.00 | — | -$0.02 | — | |
| FY 2016 | ||||||||||
| Q4 2016derived | Dec 31, 2016 | — | Apr 3, 2017 | 93 d | 10-K | $0.00 | — | — | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 21, 2016 | 52 d | 10-Q | $0.00 | — | -$0.12 | — | |
| Q2 2016 | Jun 30, 2016 | — | Aug 15, 2016 | 46 d | 10-Q | $0.00 | — | -$0.08 | — | |
| Q1 2016 | Mar 31, 2016 | — | Jun 16, 2016 | 77 d | 10-Q | $0.00 | — | -$0.05 | — | |
| FY 2015 | ||||||||||
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $0.00 | — | -$0.05 | — | |
Earlier years, FY 2015 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Moleculin Biotech, Inc. · CIK 1659617 · Engraved from SEC EDGAR